| ARZMX | VSCAX | ARZMX / VSCAX | |
| Total Expense Ratio | 1.02 | 1.10 | 93% |
| Annual Report Gross Expense Ratio | 1.02 | 1.10 | 93% |
| Fund Existence | 8 years | 27 years | - |
| Gain YTD | 1.459 | 12.643 | 12% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 5000000 | 1000 | 500,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.1B | 9.42B | 12% |
| Annual Yield % from dividends | 0.39 | 0.23 | 171% |
| Returns for 1 year | -6.91 | 18.26 | -38% |
| Returns for 3 years | 0.62 | 51.27 | 1% |
| Returns for 5 years | 8.00 | 68.92 | 12% |
| Returns for 10 years | N/A | 108.32 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PMFJX | 21.54 | 0.04 | +0.19% |
| Principal MidCap S&P 400 Index J | |||
| RIREX | 79.63 | 0.05 | +0.06% |
| American Funds Capital Income Bldr R4 | |||
| HLFMX | 9.73 | N/A | N/A |
| Harding Loevner Frontier Emerg Mkts Inst | |||
| THLCX | 23.88 | -0.38 | -1.57% |
| Thrivent Large Cap Growth S | |||
| DTEYX | 89.96 | -3.06 | -3.29% |
| BNY Mellon Technology Growth Y | |||